Investors

BioSyent is a publicly traded specialty pharmaceutical company. Our issued and outstanding common shares are listed for trading on the TSX Venture Exchange under the symbol “RX”, and OTC markets (PINK) under the ticker “BIOYF.”


View full Profile

BioSyent Releases Financial Results for Q3 and YTD 2024

Why Invest?

Track Record of Profitable Growth
57 Consecutive Profitable Quarters to Q3 2024

Strong Balance Sheet
$27.6 million Cash / $0 Debt at September 30, 2024

Well Capitalized
18% Reduction in Share Count from Share Buybacks to December 2023

Quarterly Dividend
Initiated Q4 2022

Experienced and Committed Management Team
>10 years average tenure
~25% management + director ownership

Diversified Portfolio of Innovative Products to Drive
Long-term Growth
10 Approved Products

Scalable Commercial Platform
National Field Salesforce

Market Leading FeraMAX® Pd Platform
#1 Recommended Iron Supplement in Canada for
9 Consecutive Years

2024
Quarterly Results
Q3
Q2
Q1

Q3 Results Presentation 2024

YouTube LogoCheck out our previous quarterly webcasts on our YouTube channel.

BioSyent’s Strategy

BioSyent’s strategic focus is on commercializing innovative products with recognizable brand equity sourced through international partnerships.
These products are unique due to manufacturing complexities, novel technologies, therapeutic advantages and, defendable intellectual property rights. The Company works with and supports healthcare practitioners in improving patient lives.

BioSyent’s strategy has three components:

  1. Growth (Revenue and Profit)
  2. Diversification
  3. Corporate Longevity

These three strategic components are prioritized in any investment and capital allocation decisions made by the Company, including any decision to return capital to shareholders.


2023 Annual Report

2023 marked BioSyent’s 14th consecutive year of profitability.  During 2023, BioSyent launched new products in Canada as it continued to execute on its strategic priorities of profitable growth, portfolio diversification and long-term value creation.

2023 Annual Report

Management Information Circular - April 2024

2023 Report on Modern Slavery

    Signup now to receive

    Agree with terms

    Investor FAQ

    1. Under what symbol is BioSyent Inc. listed on the stock exchange?
    BioSyent Inc. is listed on the TSX Venture Exchange (TSXV) under the stock symbol RX. Shares of BioSyent are available in the United States on the OTC Pink Marketplace under the trading symbol BIOYF.
    2. Where can I access financial reports and other statutory filings?
    In addition to this website, all historical financial reports and statutory filings can be found at www.sedarplus.ca
    3. Looking for general information about your shares?
    All shares issued by our company become the sole responsibility of the shareholder, and all shareholder records are kept by: Computershare Investor Services Inc. 9th Floor 100 University Ave. Toronto, ON M5J 2Y1 Toll free: 1.800.564.6253 | Local Tel: 416.263.9200 | Fax: 416.263.9261
    4. My share certificate says Hedley Technologies Inc. Are they still good? How do I change the name?”
    Any shares of Hedley Technologies Inc. are valid and have already been converted to BioSyent Inc. shares on a 1:1 basis. For more details, please contact: Computershare Investor Services Inc. 9th Floor 100 University Ave. Toronto, ON M5J 2Y1 http://www.computershare.com/ca-en/Pages/default.aspx